Group A and C meningococcal polysaccharide vaccines
Indication
After vaccination, this vaccine can produce humoral immune response. It is used to prevent epidemic cerebrospinal meningitis caused by group A and group C meningococci. Children over 2 years old and adults, and children under 2 years old in epidemic areas can receive emergency vaccination.
Precautions
This vaccine should not be used by people with the following conditions: 1. People with epilepsy, convulsions, brain diseases and a history of allergies; 2. People with kidney disease, heart disease and active tuberculosis; 3. People with acute infectious diseases and fever.
Packaging Specification
After reconstitution, each bottle contains 0.5 ml, and each human dose is 0.5 ml, containing 50 μg each of group A meningococcal polysaccharide and group C meningococcal polysaccharide.
Manufacturer
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd.
-
Founded in:
2003-10-08 -
Address:
No. 22 Tongji North Road, Beijing Economic and Technological Development Zone, Beijing -
Tax NO.:
91110302755250446W -
Registered Funds:
1.3321569 million yuan -
Website:
-
Email: